Dear Colleagues,

It is our pleasure to invite you to participate in three days of discussion, sharing of experience, moving the debate forward and networking at the 22nd Annual EuroMeeting in Monaco, March 8 - 10, 2010.

Whether your involvement will be as a session chair, speaker, tutorial instructor, or attendee, and whether you are a representative of a regulatory agency, academia, industry or patient group, or a student or emerging professional, we believe you can play a key role in building the success of the EuroMeeting and ensuring its place as one of the most important European conferences for professionals involved in the development of
medicines.

When deciding on the themes, we have chosen the integrated,  multidisciplinary approach, aiming to generate interest from as many disciplines as possible. We hope we have identified interesting and thought-provoking topics for the themes. With this approach we wish to create a lively platform for a debate on development and market access of medicines in Europe.

Programme development is well on its ways and you can see the direction we wish the themes to take in the following pages. We do hope that this will stimulate you to contribute with a presentation or tutorial abstract.

These abstracts are essential for the dynamics of the meeting. Monaco is an exciting venue, well known to most people. Despite being a small country, it has a lot to offer and is very hospitable and culturally interesting. No doubt there are numerous challenges around but we strongly believe you should not miss this opportunity to bring your contribution to the necessary debate on drug development. Make your plans to come to Monaco next year!

Bruno Flamion, Professor, Clinical Pharmacology, University of Namur, Belgium and Chair, Scientific Advice Working Party, EMEA

Kerstin Franzén
Senior Director, Regulatory Policy & Intelligence, Pfizer, Sweden